Mah J, Djerboua M, Groome P, Booth C, Flemming J
Can Liver J. 2022; 3(4):334-347.
PMID: 35990506
PMC: 9202739.
DOI: 10.3138/canlivj-2020-0002.
Jooste V, Bengrine-Lefevre L, Manfredi S, Quipourt V, Grosclaude P, Facy O
Cancers (Basel). 2022; 14(7).
PMID: 35406447
PMC: 8996902.
DOI: 10.3390/cancers14071675.
Gyawali B, Griffiths R, Robinson A, McInnes M, Bedard P, Booth C
Can Urol Assoc J. 2021; 16(2):26-33.
PMID: 34582333
PMC: 8932435.
DOI: 10.5489/cuaj.7246.
Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum J
Int J Colorectal Dis. 2021; 36(4):811-819.
PMID: 33528749
DOI: 10.1007/s00384-021-03861-6.
Karim S, Mackillop W, Brennan K, Peng Y, Siemens D, Krzyzanowska M
Cancer Med. 2019; 8(14):6258-6271.
PMID: 31472011
PMC: 6797575.
DOI: 10.1002/cam4.2449.
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data.
Jongeneel G, Klausch T, van Erning F, Vink G, Koopman M, Punt C
Int J Cancer. 2019; 146(11):2968-2978.
PMID: 31424568
PMC: 7187209.
DOI: 10.1002/ijc.32629.
Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer.
Karim S, Booth C, Brennan K, Peng Y, Siemens D, Krzyzanowska M
Cancer Med. 2019; 8(12):5590-5599.
PMID: 31407518
PMC: 6745837.
DOI: 10.1002/cam4.2456.
The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting.
Hall S, Griffiths R, OSullivan B, Liu F
Head Neck. 2019; 41(7):2271-2276.
PMID: 30719797
PMC: 6617819.
DOI: 10.1002/hed.25679.
Use of radiotherapy for bladder cancer: A population-based study of evolving referral and practice patterns.
Wei X, Siemens D, Mackillop W, Booth C
Can Urol Assoc J. 2018; 13(4):92-101.
PMID: 30273116
PMC: 6456345.
DOI: 10.5489/cuaj.5447.
Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario.
Brennan K, Hall S, Owen T, Griffiths R, Peng Y
Curr Oncol. 2018; 25(2):e120-e131.
PMID: 29719436
PMC: 5927791.
DOI: 10.3747/co.25.3892.
First of All, I Feel Very Loved: Humanism and Cancer Care in South India.
Booth C
J Glob Oncol. 2017; 2(6):353-355.
PMID: 28717720
PMC: 5493258.
DOI: 10.1200/JGO.2016.006296.
Is there a sex effect in colon cancer? Disease characteristics, management, and outcomes in routine clinical practice.
Quirt J, Nanji S, Wei X, Flemming J, Booth C
Curr Oncol. 2017; 24(1):e15-e23.
PMID: 28270728
PMC: 5330634.
DOI: 10.3747/co.24.3410.
Is there a gender effect in bladder cancer? A population-based study of practice and outcomes.
Patafio F, Siemens D, Wei X, Booth C
Can Urol Assoc J. 2015; 9(7-8):269-74.
PMID: 26316913
PMC: 4537340.
DOI: 10.5489/cuaj.2927.
Application status of tamoxifen in endocrine therapy for early breast cancer.
Hu Q, Luo T, Zhong X, He P, Tian T, Zheng H
Exp Ther Med. 2015; 9(6):2207-2212.
PMID: 26136961
PMC: 4473362.
DOI: 10.3892/etm.2015.2437.
Comparing effectiveness with efficacy: outcomes of palliative chemotherapy for non-small-cell lung cancer in routine practice.
Harrison L, Zhang-Salomons J, Mates M, Booth C, King W, Mackillop W
Curr Oncol. 2015; 22(3):184-91.
PMID: 26089717
PMC: 4462528.
DOI: 10.3747/co.22.2419.
Nontuberculous mycobacterial infection is associated with increased respiratory failure: a nationwide cohort study.
Yeh J, Wang Y, Lin C, Chou C, Yeh T, Wu B
PLoS One. 2014; 9(6):e99260.
PMID: 24918925
PMC: 4053398.
DOI: 10.1371/journal.pone.0099260.
Glioblastoma management in the temozolomide era: have we improved outcome?.
Lwin Z, MacFadden D, Al-Zahrani A, Atenafu E, Miller B, Sahgal A
J Neurooncol. 2013; 115(2):303-10.
PMID: 23979682
DOI: 10.1007/s11060-013-1230-3.
Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: a population-based study.
Kankesan J, Shepherd F, Peng Y, Darling G, Li G, Kong W
Curr Oncol. 2013; 20(1):30-7.
PMID: 23443880
PMC: 3557329.
DOI: 10.3747/co.20.1178.
Achieving the achievable in muscle-invasive bladder cancer.
Booth C, Mackillop W
Can Urol Assoc J. 2012; 6(4):251-2.
PMID: 23093533
PMC: 3433539.
DOI: 10.5489/cuaj.12220.
Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer.
Yu J, Simmons C, Victor J, Han D, Hogeveen S, Leighl N
Oncologist. 2011; 16(9):1307-15.
PMID: 21835896
PMC: 3228167.
DOI: 10.1634/theoncologist.2011-0079.
